Search Results - "PODDA, AUDINO"
-
1
A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country
Published in Frontiers in immunology (22-12-2017)“…Shigellosis is a mild-to-severe diarrheal infection, caused by the genus , and is responsible for significant morbidity and mortality worldwide. We evaluated…”
Get full text
Journal Article -
2
Education in Vaccinology: An Important Tool for Strengthening Global Health
Published in Frontiers in immunology (24-05-2018)“…Over the past 20 years, education of scientists and public health professionals in Vaccinology has increased dramatically. There are now many international,…”
Get full text
Journal Article -
3
Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant
Published in The Pediatric infectious disease journal (01-07-2009)“…BACKGROUND:Children have high morbidity and hospitalization rates from seasonal influenza. Meta-analyses suggest that conventional inactivated influenza…”
Get full text
Journal Article -
4
Antibodies Elicited by the Shigella sonnei GMMA Vaccine in Adults Trigger Complement-Mediated Serum Bactericidal Activity: Results From a Phase 1 Dose Escalation Trial Followed by a Booster Extension
Published in Frontiers in immunology (04-05-2021)“…is the second most deadly diarrheal disease among children under five years of age, after rotavirus, with high morbidity and mortality in developing countries…”
Get full text
Journal Article -
5
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study
Published in Frontiers in immunology (09-09-2022)“…Shigella is associated with a significant burden of disease worldwide among individuals of all ages and is the major cause of moderate and severe diarrhea in…”
Get full text
Journal Article -
6
MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults
Published in PloS one (06-02-2009)“…Pathogenic avian influenza virus (H5N1) has the potential to cause a major global pandemic in humans. Safe and effective vaccines that induce immunologic…”
Get full text
Journal Article -
7
A strategic model for developing vaccines against neglected diseases: An example of industry collaboration for sustainable development
Published in Human vaccines & immunotherapeutics (30-11-2022)“…Infectious diseases continue to disproportionately affect low- and middle-income countries (LMICs) and children aged <5 y. Developing vaccines against diseases…”
Get full text
Journal Article -
8
Booster Vaccination With GVGH Shigella sonnei 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial
Published in Frontiers in immunology (08-03-2019)“…The investigational vaccine (1790GAHB) based on GMMA (generalized modules for membrane antigens) is immunogenic, with an acceptable safety profile in adults…”
Get full text
Journal Article -
9
Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review
Published in PloS one (04-08-2016)“…In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often…”
Get full text
Journal Article -
10
Application of Transthoracic Echocardiography for Cardiac Safety Evaluation in the Clinical Development Process of Vaccines Against Streptococcus pyogenes
Published in Drugs in R&D (01-03-2024)“…Superficial infections with Streptococcus pyogenes (Strep A), pharyngitis and impetigo can induce acute rheumatic fever, an autoimmune sequela manifesting…”
Get full text
Journal Article -
11
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe
Published in EBioMedicine (01-08-2017)“…Approximately 164,000 deaths yearly are due to shigellosis, primarily in developing countries. Thus, a safe and affordable Shigella vaccine is an important…”
Get full text
Journal Article -
12
Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials
Published in The Lancet infectious diseases (01-02-2014)“…Summary Background Typhoid vaccination is a public health priority in developing countries where young children are greatly affected by typhoid fever. Because…”
Get full text
Journal Article -
13
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults
Published in EClinicalMedicine (01-09-2021)“…Shigellosis accounts for substantial morbidity and mortality worldwide and is the second most common cause of moderate and severe diarrhoea in children. This…”
Get full text
Journal Article -
14
Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination
Published in Frontiers in immunology (01-02-2024)“…Shigellosis mainly affects children under 5 years of age living in low- and middle-income countries, who are the target population for vaccination. There are,…”
Get full text
Journal Article -
15
Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture
Published in The Journal of infectious diseases (15-09-2009)“…BackgroundImmunization remains the best prevention strategy for influenza, but production constraints for egg-based influenza vaccines have prompted the…”
Get full text
Journal Article -
16
Safety, immunogenicity and dose ranging of a new Vi-CRM₁₉₇ conjugate vaccine against typhoid fever: randomized clinical testing in healthy adults
Published in PloS one (30-09-2011)“…Typhoid fever causes more than 21 million cases of disease and 200,000 deaths yearly worldwide, with more than 90% of the disease burden being reported from…”
Get full text
Journal Article -
17
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine
Published in npj vaccines (08-03-2024)“…Shigella spp. are a leading bacterial cause of diarrhea. No widely licensed vaccines are available and there is no generally accepted correlate of protection…”
Get full text
Journal Article -
18
Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic Escherichia coli Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers
Published in Journal of Virology (01-05-2006)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
19
Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against Squalene
Published in Clinical and Vaccine Immunology (01-09-2006)“…Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
20
Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines
Published in Expert review of vaccines (01-04-2003)“…Cholera toxin and Escherichia coli heat-labile enterotoxin are powerful mucosal adjuvants but their high toxicity hampers their use in humans. Site-directed…”
Get more information
Journal Article